https://doi.org/10.4081/monaldi.2024.2959
Factors influencing health-related quality of life in patients with chronic obstructive pulmonary disease: insights from the Burden of Obstructive Lung Disease Study in Fez, Morocco
Submitted: February 15, 2024
Accepted: August 26, 2024
Published: October 2, 2024
Accepted: August 26, 2024
Abstract Views: 339
PDF_EARLY VIEW: 64
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The respiratory symptoms experienced by patients with chronic obstructive pulmonary disease (COPD) are a burden on daily life. The objective of this study was to measure health-related quality of life (HRQoL) and comprehensively identify its associated factors in Moroccan COPD patients. A cross-sectional, randomized study was carried out in the city of Fes, Morocco, as part of the large multicenter Burden of Obstructive Lung Disease Study on people with COPD. Data collection was carried out using a questionnaire containing sociodemographic, clinical, and quality-of-life data. The diagnosis of COPD was based on spirometry, and quality of life was measured by the Short Form Survey (SF-12) questionnaire. Using multiple linear regression, we assessed the relationship between several sociodemographic and clinical factors and SF-12 mental and physical quality-of-life scores. A total of 107 patients were included, with a male predominance (63.6%) and the most common age category being 60 years and older (51.4%). Additionally, 46.7% of participants were classified as Global Initiative for Obstructive Lung Disease (GOLD) stage 1. The mean SF-12 mental component score was 41.32±9.18, and the mean SF-12 physical component score was 41.91±11.93. Multivariate analysis revealed that a greater mental HRQoL was associated with the male gender, a body mass index of 25 or higher, and GOLD stage 1, while a greater physical HRQoL was associated with the male gender, an age less than 60 years, absence of respiratory comorbidities, and GOLD stage 1. Our results show low scores of the mental and physical components of HRQoL in COPD patients in Morocco, suggesting the implementation of measures to reduce first the prevalence of the disease and then adopt an appropriate COPD management strategy to improve those people's quality of life.
Vijayan VK. Chronic obstructive pulmonary disease. Indian J Med Res 2013;137:251-69.
Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev 2009;18:213-21.
DOI: https://doi.org/10.1183/09059180.00003609
Marsh S, Aldington S, Shirtcliffe P, et al. Smoking and COPD: what really are the risks? Eur Respir J 2006;28:883-4.
DOI: https://doi.org/10.1183/09031936.06.00074806
Celli BR, Decramer M, Wedzicha JA, et al. An Official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;191:e4-27.
Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ 2022;378:e069679.
DOI: https://doi.org/10.1136/bmj-2021-069679
Szalontai K, Gémes N, Furák J, et al. Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer. J Clin Med 2021;10:2889.
DOI: https://doi.org/10.3390/jcm10132889
WHO. Bronchopneumopathie chronique obstructive (BPCO). Available from: https://www.who.int/fr/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed on:11/06/2021.
El Rhazi K, Nejjari C, BenJelloun MC, et al. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: results from the BOLD study. Int J Tuberc Lung Dis 2016;20:136-41.
DOI: https://doi.org/10.5588/ijtld.15.0029
Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011;105:57-66.
DOI: https://doi.org/10.1016/j.rmed.2010.09.004
Horner A, Burghuber OC, Hartl S, et al. Quality of life and limitations in daily life of stable copd outpatients in a real-world setting in Austria - results from the CLARA project. Int J Chron Obstruct Pulmon Dis 2020;15:1655-63.
DOI: https://doi.org/10.2147/COPD.S252033
Kharbanda S, Anand R. Health-related quality of life in patients with chronic obstructive pulmonary disease: a hospital-based study. Indian J Med Res 2021;153:459-64.
DOI: https://doi.org/10.4103/ijmr.IJMR_1812_18
Okutan O, Tas D, Demirer E, Kartaloglu Z. Evaluation of quality of life with the chronic obstructive pulmonary disease assessment test in chronic obstructive pulmonary disease and the effect of dyspnea on disease-specific quality of life in these patients. Yonsei Med J 2013;54:1214-9.
DOI: https://doi.org/10.3349/ymj.2013.54.5.1214
Engström CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001;18:69-76.
DOI: https://doi.org/10.1183/09031936.01.00044901
Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD 2005;2:277-83.
DOI: https://doi.org/10.1081/COPD-200057610
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
DOI: https://doi.org/10.1164/rccm.200703-456SO
Obtel M, El Rhazi K, Elhold S, et al. Cross-cultural adaptation of the 12-item short-form survey instrument in a Moroccan representative survey. SAJID 2013;28:166-71.
DOI: https://doi.org/10.1080/10158782.2013.11441540
Sijtsma K, van der Ark LA. A tutorial on how to do a Mokken scale analysis on your test and questionnaire data. Br J Math Stat Psychol 2017;70:137-58.
DOI: https://doi.org/10.1111/bmsp.12078
Stochl J, Jones PB, Croudace TJ. Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Medical Research Methodology 2012;12:74.
DOI: https://doi.org/10.1186/1471-2288-12-74
Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
DOI: https://doi.org/10.1097/00005650-199603000-00003
McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
DOI: https://doi.org/10.1097/00005650-199303000-00006
Rahman MM, Siddiqui MMR. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Anwer Khan Mod Med Coll J 2017;7:4.
DOI: https://doi.org/10.3329/akmmcj.v7i1.31596
Ware J, Kosinski M, Keller S. SF-12: How to score the SF-12 physical and mental health summary scales. Boston, MA: The Health Institute, New England Medical Center; 1998.
Perez T, Serrier P, Pribil C, Mahdad A. BPCO et qualité de vie : impact de la maladie en médecine générale en France. Available from: https://www.em-consulte.com/article/780851/bpco-et-qualite-de-vie-impact-de-la-maladie-en-med. Accessed on: 2/06/2021.
Zhu B, Wang Y, Ming J, et al. Disease burden of COPD in China: a sstematic review. COPD 2018;13:1353-64.
DOI: https://doi.org/10.2147/COPD.S161555
Njoku CM, Alqahtani JS, Wimmer BC, et al. Risk factors and associated outcomes of hospital readmission in COPD: a systematic review. Respir Med 2020;173:105988.
DOI: https://doi.org/10.1016/j.rmed.2020.105988
Garrido PC, Díez J de M, Gutiérrez JR, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006;4:31.
DOI: https://doi.org/10.1186/1477-7525-4-31
de Torres JP, Casanova C, Hernández C, et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes 2006;4:72.
DOI: https://doi.org/10.1186/1477-7525-4-72
Martín A, Rodríguez-González Moro JM, Izquierdo JL, et al. Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study. Int J Chron Obstruct Pulmon Dis 2008;3:683-92.
DOI: https://doi.org/10.2147/COPD.S4791
van Manen JG, Bindels PJE, Dekker FW, et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol 2003;56:1177-84.
DOI: https://doi.org/10.1016/S0895-4356(03)00208-7
Zhou YM, Wang C, Yao WZ, et al. The quality of life of patients with chronic obstructive pulmonary disease and correlated factors. Zhonghua Jie He He Hu Xi Za Zhi 2009;32:248-52. [Article in Chinese].
Ngo CQ, Phan PT, Vu GV, et al. Effects of different comorbidities on health-related quality of life among respiratory patients in Vietnam. J Clin Med 2019;8:214.
DOI: https://doi.org/10.3390/jcm8020214
Ben Sassi S, Rouis H, Moussa C, et al. Impact de l’obésité sur la sévérité de la bronchopneumopathie chronique obstructive. Revue Des Maladies Respiratoires Actualités 2022;14:94. [Article in French].
DOI: https://doi.org/10.1016/j.rmra.2021.11.101
Wacker ME, Hunger M, Karrasch S, et al. Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population. BMC Pulm Med 2014;14:134.
DOI: https://doi.org/10.1186/1471-2466-14-134
Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: a new era in clinical research. Perspect Clin Res 2011;2:137-44.
DOI: https://doi.org/10.4103/2229-3485.86879
Dal Negro RW, Bonadiman L, Tognella S, et al. Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J Chron Obstruct Pulmon Dis 2014;9:675-83.
DOI: https://doi.org/10.2147/COPD.S63485
Ethics Approval
The study was approved by the University Hospital Ethics Committee of the Faculty of Medicine, Pharmacy and Dental Medicine of Fes (FMPDF) and the Hassan II University Hospital, Fez, Morocco (Serial Number: AR MOR v4_14 Sep 2009).How to Cite
Maiouak, Moncef, Vanessa Garcia-Larsen, Soumaya Benmaamar, Ibtissam El Harch, Mohamed El Biaz, Chakib Nejjari, Mohammed Chakib Benjelloun, and Karima El Rhazi. 2024. “Factors Influencing Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease: Insights from the Burden of Obstructive Lung Disease Study in Fez, Morocco”. Monaldi Archives for Chest Disease, October. https://doi.org/10.4081/monaldi.2024.2959.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Iqbal Akhtar Khan, Paola Pierucci, Nicolino Ambrosino, COPD patients’ pre-flight check: A narrative review , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Megha Hegde, Saurav Raj, Aishwarya S Pattanshetti, Sanatkumar Bharamu Nyamagoud, Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score , Monaldi Archives for Chest Disease: Early Access
- M. Malerba, G. Romanelli, Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease , Monaldi Archives for Chest Disease: Vol. 71 No. 2 (2009): Pulmonary series
- Murali Mupparapu, Rajesh Venkataram, Nandakishore Baikunje, Ivor D'sa, Chandramouli Mandya Thimmaiah, Assessment of left ventricular function in subjects with chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Early Access
- I. Chkhaidze, T. Maglakelidze, N. Khaltaev, Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- Silvia Porcu, Antonella Mandas, How to evaluate Quality of Life , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Kranti Garg, Preeyati Chopra, Jasmin Garg, Deepak Goyal, Darshana KE, Vishal Chopra, Psychological morbidity and quality of life of patients with pulmonary tuberculosis , Monaldi Archives for Chest Disease: Early Access
- Alberto Cester, Monica Maselli, Francesco Bolzetta, How to define the therapeutic limits , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Emel Cireli, Aydan Mertoğlu, The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Bruno Balbi, Claudio Marcassa, Fabrizio Pisani, Giacomo Corica, Antonio Spanevello, Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple? , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
You may also start an advanced similarity search for this article.
